1
|
Farina MP, Klopack ET, Umberson D, Crimmins EM. The embodiment of parental death in early life through accelerated epigenetic aging: Implications for understanding how parental death before 18 shapes age-related health risk among older adults. SSM Popul Health 2024; 26:101648. [PMID: 38596364 PMCID: PMC11002886 DOI: 10.1016/j.ssmph.2024.101648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Revised: 02/25/2024] [Accepted: 02/27/2024] [Indexed: 04/11/2024] Open
Abstract
Parental death in early life has been linked to various adverse health outcomes in older adulthood. This study extends prior research to evaluate how parental death in early life is tied to accelerated epigenetic aging, a potentially important biological mechanism from which social and environmental exposures impact age-related health. We used data from the 2016 Venous Blood Study (VBS), a component of the Health and Retirement Study (HRS), to examine the association between parental death in early life and accelerated epigenetic aging as measured by three widely used epigenetic clocks (PCPhenoAge, PCGrimAge, and DunedinPACE). We also assessed whether some of the association is explained by differences in educational attainment, depressive symptoms, and smoking behavior. Methods included a series of linear regression models and formal mediation analysis. Findings indicated that parental death in early life is associated with accelerated epigenetic aging for PCPhenoAge and DunedinPACE. The inclusion of educational attainment, depressive symptoms, and smoking behavior attenuated this association, with formal mediation analysis providing additional support for these observations. Parental death in early life may be one of the most difficult experiences an individual may face. The elevated biological risk associated with parental death in early life may operate through immediate changes but also through more downstream risk factors. This study highlights how early life adversity can set in motion biological changes that have lifelong consequences.
Collapse
Affiliation(s)
- Mateo P. Farina
- Department of Human Development and Family Sciences, University of Texas at Austin, United States
- Population Research Center, University of Texas at Austin, United States
| | - Eric T. Klopack
- Davis School of Gerontology, University of Southern California, United States
| | - Debra Umberson
- Population Research Center, University of Texas at Austin, United States
- Department of Sociology, University of Texas at Austin, United States
| | - Eileen M. Crimmins
- Davis School of Gerontology, University of Southern California, United States
| |
Collapse
|
2
|
Erdoğan MM, Kocataş S. The prevalence of smoking among soldiers of the gendarmerie in a provincial center and affecting factors: A cross-sectional study from Turkey . ARCHIVES OF ENVIRONMENTAL & OCCUPATIONAL HEALTH 2023; 78:347-356. [PMID: 37788125 DOI: 10.1080/19338244.2023.2262923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Accepted: 09/17/2023] [Indexed: 10/05/2023]
Abstract
Determining the smoking rates and nicotine dependency levels of soldiers can be a guide in smoking cessation interventions and developing a policy for smoking prevention for soldiers serving in military units. The cross-sectional study was conducted with a total of 313 soldiers stationed in gendarmerie units in a city center in the Central Anatolian Region of Turkey. Data were collected between 01.06.2021 and 31.07.2021 by face-to-face interview technique using Personal Information Form and Fagerström Nicotine Addiction Test. It was determined that 54.6% of the participants smoked, 87.1% had low-moderate nicotine addictions, and 94.9% were smokers in their friends' circle. It was revealed that the prevalence of smoking among the participants was high, and the nicotine addiction levels of the participants working in the "Prison" unit were higher.
Collapse
Affiliation(s)
| | - Semra Kocataş
- Department of Nursing, Sivas Cumhuriyet University, Sivas, Turkey
| |
Collapse
|
3
|
Liu M, Zheng M, He S. Association between tobacco smoking and heart disease in older adults: a cross-sectional study based on the Chinese Longitudinal Healthy Longevity Survey. ANNALS OF TRANSLATIONAL MEDICINE 2023; 11:63. [PMID: 36819549 PMCID: PMC9929806 DOI: 10.21037/atm-22-6344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/16/2022] [Accepted: 01/06/2023] [Indexed: 01/15/2023]
Abstract
Background The association between the risk of heart disease and tobacco smoking has been studied in previous work, but there are arguments among various population. We aimed to investigate the association between heart disease incidence and smoking status among older adults. Methods A cross-sectional analysis was conducted with 10,891 older adults in the 2 most recent waves of the Chinese Longitudinal Healthy Longevity Survey (CLHLS), 2011-2014 and 2014-2018. The data included individual weighting variables to ensure they were nationally representative. The parameters consisted of age, sex, body mass index (BMI), smoking status, and disease history was collected. Smoking measures included current/former/never status, pack-years and the time to first cigarette. Heart disease included coronary artery disease, arrhythmias, heart failure, valve diseases and other heart conditions. Respondents with missed values were excluded. Multivariable logistic regression analyses were performed. Results Among the 10,006 respondents included in the analyses, 4,501 (44.9%) were men. The median age was 88 years old [interquartile range (IQR), 78-96]. A total of 6,713 respondents (67.1%) were nonsmokers, 1,695 respondents (16.9%) were former smokers, and 1,598 respondents (16.0%) were current smokers. The incidence of heart disease was significantly higher in smokers compared with nonsmokers (14.5% vs. 12.8%, P=0.018). Female smokers and those over 80 years old had higher morbidity than male smokers. After adjusting for sex, age, BMI, hypertension, diabetes, area of residency, alcohol status, and exercise status, smokers still had an increased risk of heart disease [odds ratio (OR) 1.29, 95% confidential interval (CI): 1.10-1.50, P=0.001]. The incidence of heart disease also increased with higher intensity of smoking for each additional pack-year (OR 1.01, 95% CI: 1.00-1.02, P=0.011). Conclusions For elderly adults, current or former smoking was largely associated with heart disease incidence, especially in females and those over 80 years old. These variables could be considered for inclusion in future heart disease risk prediction models.
Collapse
Affiliation(s)
- Ming Liu
- Department of Cardiology, Cardiac Catheterization Room, West China Hospital of Sichuan University, Chengdu, China
| | - Mingxia Zheng
- Department of Cardiology, Cardiac Catheterization Room, West China Hospital of Sichuan University, Chengdu, China
| | - Sen He
- Department of Cardiology, Cardiac Catheterization Room, West China Hospital of Sichuan University, Chengdu, China
| |
Collapse
|
4
|
Hoballah A, El Haidari R, Badran R, Jaber A, Mansour S, Abou-Abbas L. Smoking status and SARS-CoV-2 infection severity among Lebanese adults: a cross-sectional study. BMC Infect Dis 2022; 22:746. [PMID: 36153476 PMCID: PMC9509589 DOI: 10.1186/s12879-022-07728-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Accepted: 09/14/2022] [Indexed: 01/08/2023] Open
Abstract
Background A paradoxical hypothesis about the effect of smoking on patients infected with severe acute respiratory syndrom 2 (SARS-CoV-2) infection still exists. Furthermore, gender-discrepancy in the impact of smoking on COVID-19 severity was given little attention. Thus, the aims of the present study were to evaluate the prevalence of smoking and the COVID-19 infection severity in a sample of adult patients diagnosed with COVID-19 and to explore the relationship between smoking status and SARS-CoV-2 infection severity in the overall sample and stratified by gender. Methods A retrospective analytical study was conducted on patients diagnosed with COVID-19 cases between December, 2020 and April, 2021 from three leading laboratories in Lebanon. Sociodemographic characteristics, smoking status and clinical symptoms were collected. Multinomial logistic regression analysis was used to explore the relationship between smoking status and SARS-CoV-2 infection severity. Results A total of 901 confirmed COVID-19 cases participated in the study, 50.8% were females. The mean age of patients was 38.4 years (SD = 15.3). Of the total sample, 521(57.8%) were current smokers. Regarding infection severity, 14.8% were asymptomatic, 69.9% had mild symptoms, while 15.3% had severe infection. In the overall sample, smoking status, smoking types and dose–response were not significantly associated with infection severity. Upon stratifying the entire sample by gender, no association was found between all the considered variables with infection severity among females. However, a significant association was found among male with mild infection compared to their asymptomatic counterparts (OR = 1.78 95% CI (1.01–3.13)). Waterpipe smoking was found to be associated with infection severity among male with mild infection (OR 2.64 (95% CI 1.32–5.27)) and severe infection 2.79, 95% CI (1.19–6.53) compared to their asymptomatic counterparts. Conclusion Our fundings highlight sex differences in the association between tobacco smoking and COVID-19 severity. Current tobacco smoking was not associated with SARS-CoV-2 infection severity among female patients, however, tobacco smoking, particularly waterpipe, was found to be associated with infection severity among male. Thus, the battle against smoking should continue by assisting smokers to successfully and permanently quit.
Collapse
|
5
|
Sex-Related Differences in Oxidative, Platelet, and Vascular Function in Chronic Users of Heat-not-Burn vs. Traditional Combustion Cigarettes. Antioxidants (Basel) 2022; 11:antiox11071237. [PMID: 35883727 PMCID: PMC9311916 DOI: 10.3390/antiox11071237] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2022] [Revised: 06/16/2022] [Accepted: 06/22/2022] [Indexed: 02/04/2023] Open
Abstract
Smoking is still a major cardiovascular risk factor, despite many public awareness campaigns and dedicated interventions. Recently, modified risk products (MRP), e.g., heat-not-burn cigarettes (HNBCs), have been introduced as surrogates of traditional combustion cigarettes (TCCs). Although these products are promoted as healthier than TCCs, few studies have been conducted to assess it. This work is a sex-focused sub-study of a prospective observational study in which apparently healthy chronic TCC smokers were age-matched with regular HNBC users. Blood samples were collected for biochemical assays and blood pressure and flow-mediated dilation (FMD) were measured. Out of 60 subjects, 33 (55%) were women, and 27 (45%) men, with 11 (33%) vs. 9 (33%) non-smokers, respectively, 10 (30%) vs. 10 (37%) TCC smokers, and 12 (36%) vs. 8 (30%) HNBC smokers (p = 0.946). Bivariate and multivariable analyses showed no statistically significant between-sex differences in NO, H2O2, sCD40L, sNox2-dp, sP-selectin, platelet aggregation, cotinine or FMD, overall, in non-smokers, in TCC smokers, or in HNBC smokers (all p > 0.05). HNBCs appeared safer than TCCs when focusing on Nox2-dp (p = 0.026) and sP-selectin (p = 0.050) but had similar levels of the other measured markers. In conclusion, HNBCs have similar detrimental effects on women and men’s oxidative stress (H2O2: p = 0.49; sNox2-dp: p = 0.31) and platelet activation (sP-selectin: p = 0.33; platelet aggregation p = 0.87).
Collapse
|
6
|
Skalny AV, Serebryansky EP, Korobeinikova TV, Tsatsakis A, Vardavas C, Paoliello MMB, Sotnikova TI, Aschner M, Tinkov AA. Smoking is associated with altered serum and hair essential metal and metalloid levels in women. Food Chem Toxicol 2022; 167:113249. [PMID: 35728725 DOI: 10.1016/j.fct.2022.113249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Revised: 06/09/2022] [Accepted: 06/16/2022] [Indexed: 11/25/2022]
Abstract
The objective of the study was to evaluate the association between smoking and essential metal (Co, Cr, Cu, Fe, Mn, V, Zn) and metalloid (Se) levels in hair and serum of adult women using inductively coupled plasma-mass spectrometry (ICP-MS). In this cross-sectional study, a total of 344 women 20-70 years old including 199 smokers and 145 non-smoking women were enrolled. Serum Cu, Fe, and Zn levels in smoking women were found to be 6%, 8%, and 3% lower of levels in non-smokers, respectively. In contrast, circulating Mn, V, and especially Cr concentrations in smoking women exceeded the respective values in non-smoking women by 5%, 14%, and 54%. Hair Fe and Se levels in smoking women were 17% and 23% lower as compared to non-smoking controls, respectively. In multiple regression models, smoking severity was inversely associated with serum and hair Se concentrations, whereas the relationship to serum and hair Cr was positive. In addition, serum Zn and hair Fe levels were found to be inversely associated with the number of cigarettes per day. These findings hypothesize that health hazards of smoking may be at least in part be mediated by alteration in essential metal and metalloid metabolism.
Collapse
Affiliation(s)
- Anatoly V Skalny
- IM Sechenov First Moscow State Medical University (Sechenov University), 119435, Moscow, Russia
| | | | - Tatiana V Korobeinikova
- IM Sechenov First Moscow State Medical University (Sechenov University), 119435, Moscow, Russia
| | - Aristidis Tsatsakis
- IM Sechenov First Moscow State Medical University (Sechenov University), 119435, Moscow, Russia; Laboratory of Toxicology, Medical School, University of Crete, Voutes, 700 13, Heraklion, Crete, Greece
| | - Constantine Vardavas
- Laboratory of Toxicology, Medical School, University of Crete, Voutes, 700 13, Heraklion, Crete, Greece; Center for Global Tobacco Control, Harvard School of Public Health, 02115, Boston, United States
| | - Monica M B Paoliello
- Department of Molecular Pharmacology, Albert Einstein College of Medicine, 10461, Bronx, NY, USA
| | - Tatiana I Sotnikova
- IM Sechenov First Moscow State Medical University (Sechenov University), 119435, Moscow, Russia; City Clinical Hospital n. a, S.P. Botkin of the Moscow City Health Department, 125284, Moscow, Russia
| | - Michael Aschner
- Department of Molecular Pharmacology, Albert Einstein College of Medicine, 10461, Bronx, NY, USA
| | - Alexey A Tinkov
- IM Sechenov First Moscow State Medical University (Sechenov University), 119435, Moscow, Russia; Laboratory of Ecobiomonitoring and Quality Control, Yaroslavl State University, 150003, Yaroslavl, Russia.
| |
Collapse
|
7
|
Huynh N, Tariq S, Charron C, Hayes T, Bhanushali O, Kaur T, Jama S, Ambade P, Bignell T, Hegarty T, Shorr R, Pakhale S. Personalised multicomponent interventions for tobacco dependence management in low socioeconomic populations: a systematic review and meta-analysis. J Epidemiol Community Health 2022; 76:jech-2021-216783. [PMID: 35623792 PMCID: PMC9279829 DOI: 10.1136/jech-2021-216783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Accepted: 03/14/2022] [Indexed: 11/07/2022]
Abstract
BACKGROUND There remains a disproportionally high tobacco smoking rate in low-income populations. Multicomponent tobacco dependence interventions in theory are effective. However, which intervention components are necessary to include for low socioeconomic status (SES) populations is still unknown. OBJECTIVE To assess the effectiveness of multicomponent tobacco dependence interventions for low SES and create a checklist tool examining multicomponent interventions. METHODS EMBASE and MEDLINE databases were searched to identify randomised controlled trials (RCTs) published with the primary outcome of tobacco smoking cessation measured at 6 months or post intervention. RCTs that evaluated tobacco dependence management interventions (for reduction or cessation) in low SES (experience of housing insecurity, poverty, low income, unemployment, mental health challenges, illicit substance use and/or food insecurity) were included. Two authors independently abstracted data. Random effects meta-analysis and post hoc sensitivity analysis were performed. RESULTS Of the 33 included studies, the number of intervention components ranged from 1 to 6, with smoking quit rates varying between 1% and 36.6%. Meta-analysis revealed that both the 6-month and 12-month outcome timepoints, multicomponent interventions were successful in achieving higher smoking quit rates than the control (OR 1.64, 95% Cl 1.41 to 1.91; OR 1.74, 95% Cl 1.30 to 2.33). Evidence of low heterogeneity in the effect size was observed at 6-month (I2=26%) and moderate heterogeneity at 12-month (I2=56%) outcomes. CONCLUSION Multicomponent tobacco dependence interventions should focus on inclusion of social support, frequency and duration of components. Employing community-based participatory-action research approach is essential to addressing underlying psychosocioeconomic-structural factors, in addition to the proven combination pharmacotherapies. PROSPERO REGISTRATION NUMBER CRD42017076650.
Collapse
Affiliation(s)
- Nina Huynh
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
| | - Saania Tariq
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
| | | | - Tavis Hayes
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
- Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - Onkar Bhanushali
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
- Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - Tina Kaur
- Nursing, University of Toronto, Toronto, Ontario, Canada
| | - Sadia Jama
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
| | - Preshit Ambade
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
| | - Ted Bignell
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
| | - Terry Hegarty
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
| | - Risa Shorr
- Learning Services, Ottawa Hospital, Ottawa, Ontario, Canada
| | - Smita Pakhale
- The Bridge Engagement Centre, Ottawa, Ontario, Canada
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
- Department of Medicine, Ottawa Hospital, Ottawa, Ontario, Canada
| |
Collapse
|
8
|
Sreekantaswamy SA, Butler DC, Shah AA. Reframing aging in dermatology: The role of the dermatologist in healthy aging. Int J Womens Dermatol 2022; 7:529-532. [PMID: 35005175 PMCID: PMC8721070 DOI: 10.1016/j.ijwd.2021.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2021] [Revised: 08/27/2021] [Accepted: 08/27/2021] [Indexed: 10/26/2022] Open
Abstract
Dermatology is often tasked with balancing the clinical appearance of aging skin with the reality of what healthy aging means. In this article, we review some of the core principles of healthy aging and explore common misconceptions, both from patients and physicians, regarding aging. Recognition of the basics of healthy aging and awareness of these aging myths can empower providers to advise patients accurately and productively regarding their aging goals.
Collapse
Affiliation(s)
- Shreya A Sreekantaswamy
- Department of Dermatology, University of California, San Francisco, California.,University of Utah, School of Medicine, Salt Lake City, Utah
| | - Daniel C Butler
- Department of Dermatology, University of California, San Francisco, California
| | - Amit A Shah
- Division of Community Internal Medicine, Mayo Clinic, Scottsdale, Arizona
| |
Collapse
|
9
|
Finch CE, Haghani A. Gene-Environment Interactions and Stochastic Variations in the Gero-Exposome. J Gerontol A Biol Sci Med Sci 2021; 76:1740-1747. [PMID: 33580247 PMCID: PMC8436990 DOI: 10.1093/gerona/glab045] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Indexed: 12/11/2022] Open
Abstract
The limited heritability of human life spans suggests an important role for gene-environment (G × E) interactions across the life span (T), from gametes to geronts. Multilevel G × E × T interactions of aging phenotypes are conceptualized in the Gero-Exposome as Exogenous and Endogenous domains. Stochastic variations in the Endogenous domain contribute to the diversity of aging phenotypes, shown for the diversity of inbred Caenorhabditis elegans life spans in the same culture environment, and for variegated gene expression of somatic cells in nematodes and mammals. These phenotypic complexities can be analyzed as 3-way interactions of gene, environment, and stochastic variations, the Tripartite Phenotype of Aging. Single-cell analyses provide tools to explore this broadening frontier of biogerontology.
Collapse
Affiliation(s)
- Caleb E Finch
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA
- Dornsife College, University of Southern California, Los Angeles, CA
| | - Amin Haghani
- Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA
| |
Collapse
|
10
|
Khalil A, Dhingra R, Al-Mulki J, Hassoun M, Alexis N. Questioning the sex-specific differences in the association of smoking on the survival rate of hospitalized COVID-19 patients. PLoS One 2021; 16:e0255692. [PMID: 34351990 PMCID: PMC8341532 DOI: 10.1371/journal.pone.0255692] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Accepted: 07/21/2021] [Indexed: 02/07/2023] Open
Abstract
Introduction In the absence of a universally accepted association between smoking and COVID-19 health outcomes, we investigated this relationship in a representative cohort from one of the world’s highest tobacco consuming regions. This is the first report from the Middle East and North Africa that tackles specifically the association of smoking and COVID-19 mortality while demonstrating a novel sex-discrepancy in the survival rates among patients. Methods Clinical data for 743 hospitalized COVID-19 patients was retrospectively collected from the leading centre for COVID-19 testing and treatment in Lebanon. Logistic regression, Kaplan-Meier survival curves and Cox proportional hazards model adjusted for age and stratified by sex were used to assess the association between the current cigarette smoking status of patients and COVID-19 outcomes. Results In addition to the high smoking prevalence among our hospitalized COVID-19 patients (42.3%), enrolled smokers tended to have higher reported ICU admissions (28.3% vs 16.6%, p<0.001), longer length of stay in the hospital (12.0 ± 7.8 vs 10.8 days, p<0.001) and higher death incidences as compared to non-smokers (60.5% vs 39.5%, p<0.001). Smokers had an elevated odds ratio for death (OR = 2.3, p<0.001) and for ICU admission (OR = 2.0, p<0.001) which remained significant in a multivariate regression model. Once adjusted for age and stratified by sex, our data revealed that current smoking status reduces survival rate in male patients ([HR] = 1.9 [95% (CI), 1.029–3.616]; p = 0.041) but it does not affect survival outcomes among hospitalized female patients([HR] = 0.79 [95% CI = 0.374–1.689]; p = 0.551). Conclusion A high smoking prevalence was detected in our hospitalized COVID-19 cohort combined with worse prognosis and higher mortality rate in smoking patients. Our study was the first to highlight potential sex-specific consequences for smoking on COVID-19 outcomes that might further explain the higher vulnerability to death from this disease among men.
Collapse
Affiliation(s)
- Athar Khalil
- Clinical Research Unit, Rafik Hariri University Hospital, Beirut, Lebanon
- * E-mail: (AK); (MH)
| | - Radhika Dhingra
- Department of Environmental Sciences and Engineering, Gillings School of Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America
- Institute for Environmental Health Solutions, University of North Carolina, Chapel Hill, North Carolina, United States of America
| | - Jida Al-Mulki
- Department of Pulmonary and Intensive Care Unit, Rafik Hariri University Hospital, Beirut, Lebanon
| | - Mahmoud Hassoun
- Department of Pulmonary and Intensive Care Unit, Rafik Hariri University Hospital, Beirut, Lebanon
- * E-mail: (AK); (MH)
| | - Neil Alexis
- Center for Environmental Medicine Asthma and Lung Biology, University of North Carolina, Chapel Hill, North Carolina, United States of America
| |
Collapse
|
11
|
Matera MG, Ora J, Calzetta L, Rogliani P, Cazzola M. Sex differences in COPD management. Expert Rev Clin Pharmacol 2021; 14:323-332. [PMID: 33560876 DOI: 10.1080/17512433.2021.1888713] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Introduction: A growing body of evidence indicates that prevalence of chronic obstructive pulmonary disease (COPD) has been increasing more rapidly among women compared to men, but the available data on the differences between the sexes in the responses to the various COPD therapies are still scarce.Areas covered: The aim of this narrative review is to provide an overview of current knowledge on sex differences in COPD management.Expert opinion: There is no solid evidence of sex differences in response to usual COPD treatments but there are sex-related differences in management of patients with a clinical diagnosis of COPD. It is difficult to explain the reason for these differences, but most likely they are due to local prescribing habits, rather than solid scientific reasons. However, there are also signals of different sex-related responses, the qualification and quantification of which is difficult with the information currently available. These signals should lead to the inclusion of more women in clinical trials, but also to the design of prospective clinical studies to assess the possible differences linked to sex in COPD treatment responses, whose identification is an important step toward the definition of personalized COPD therapy.
Collapse
Affiliation(s)
- Maria Gabriella Matera
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Josuel Ora
- Respiratory Diseases Unit, "Tor Vergata" University Hospital, Rome, Italy
| | - Luigino Calzetta
- Unit of Respiratory Disease and Lung Function Dept. Medicine and Surgery, University of Parma, ParmaItaly
| | - Paola Rogliani
- Respiratory Diseases Unit, "Tor Vergata" University Hospital, Rome, Italy.,Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy
| | - Mario Cazzola
- Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy
| |
Collapse
|
12
|
Baroni C, Lionetti V. The impact of sex and gender on heart-brain axis dysfunction: current concepts and novel perspectives. Can J Physiol Pharmacol 2020; 99:151-160. [PMID: 33002366 DOI: 10.1139/cjpp-2020-0391] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
The heart-brain axis (HBA) recapitulates all the circuits that regulate bidirectional flow of communication between heart and brain. Several mechanisms may underlie the interdependent relationship involving heterogeneous tissues at rest and during specific target organ injury such as myocardial infarction, heart failure, arrhythmia, stroke, mood disorders, or dementia. In-depth translational studies of the HBA dysfunction under single-organ injury should include both male and female animals to develop sex- and gender-oriented prevention, diagnosis, and treatment strategies. Indeed, sex and gender are determining factors as females and males exhibit significant differences in terms of susceptibility to risk factors, age of onset, severity of symptoms, and outcome. Despite most studies having focused on the male population, we have conducted a careful appraisal of the literature investigating HBA in females. In particular, we have (i) analyzed sex-related heart and brain illnesses, (ii) recapitulated the most significant studies simultaneously conducted on cardio- and cerebro-vascular systems in female populations, and (iii) hypothesized future perspectives for the development of a gender-based approach to HBA dysfunction. Although sex- and gender-oriented research is at its infancy, the impact of sex on HBA dysfunction is opening unexpected new avenues for managing the health of female subjects exposed to risk of lifestyle multi-organ disease.
Collapse
Affiliation(s)
- Carlotta Baroni
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy
| | - Vincenzo Lionetti
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.,UOS Anesthesiology and Intensive Care Medicine, Fondazione Toscana G. Monasterio, Pisa, Italy
| |
Collapse
|
13
|
Bounedjar A, Benkali R, Badoui L, Abada M, Moumeni A, Marouani A, Sedkaoui C, Ammour H, Dib A, Braikia S, Reggad R, Zidane H, Taieb L, Mahfouf H, Belacel A, Mechiat Z, Maachou Y, Souilah S, Gamaz M, Reguig F, Tabouri S, Bouannika M, Ghomari S, Rostane A, Ougdi W, Belbachir L, Bousahba A, Seghier F, Megaiz A, Mesli Mohamed A, Gharnaout M, Ihadadenne D, Bensalem A, Namous Anissa S, Djeghim S, Khelifi Touhami S, Bouzid K, Kerboua E, Oukkal M, Hadjam F, Smaili F, Bekkouche S, Zidouni N, Mekideche D, Mebrek A, Douagui H, Abdelaziz R, Lemdani M, Malki G, Fissah A, Larbaoui B, Sadji N, Zeroual S, Filali T, Ayadi L, Youcef Ali L, Djebbar A, Heddane R, Haddad B, Djedi H, Yousfi A, Debbah L, Boualga K, Ouali L, Guettaf Fatima Z, Moussei A, Houri M, Haddouche A, Kedar M. Incidence of lung cancer in males and females in Algeria: The lung cancer registry in Algeria (LuCaReAl). Cancer Epidemiol 2020; 69:101799. [PMID: 32977217 DOI: 10.1016/j.canep.2020.101799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 08/11/2020] [Accepted: 08/15/2020] [Indexed: 10/23/2022]
Abstract
BACKGROUND Lung cancer is a major cause of death worldwide. However, few data on incidence, histologic types and mortality rates of lung cancer were available for Algeria. METHODS LuCaReAl is an ongoing descriptive, non-interventional, national, multicenter, prospective and longitudinal study conducted in Algeria, among oncologists and pulmonologists in public community and university hospitals. Median and interquartile ranges are displayed. RESULTS Between July 2016 and July 2017, 897 patients were included. Overall incidence of lung cancer was 3.4 [3.2;3.6] cases per 100,000 inhabitants; overall incidence by sex was 5.8 [5.4;6.2] for males and 1.0 [0.8;1.1] for females. Adenocarcinoma was the most common histologic type of cancer. Most tumors were diagnosed at Stage IV. CONCLUSION The first results from the LuCaReAl study in Algeria showed that most patients are diagnosed with lung cancer at an advanced stage. The ongoing follow-up will next provide data on the survival and mortality rates.
Collapse
Affiliation(s)
- Adda Bounedjar
- University of Blida 1, Faculty of Medicine, BP 270, Route de soumaa, Blida, Algeria.
| | - Radjâa Benkali
- University of Blida 1, Faculty of Medicine, BP 270, Route de soumaa, Blida, Algeria
| | - Louisa Badoui
- University of Blida 1, Faculty of Medicine, BP 270, Route de soumaa, Blida, Algeria
| | - Mohamed Abada
- University of Blida 1, Faculty of Medicine, BP 270, Route de soumaa, Blida, Algeria
| | - Abdelhak Moumeni
- Department of Pneumology, Center University of Setif, Mohamed Abdenour Street, 19000 Setif, Algeria
| | - Amina Marouani
- Department of Pneumology, Center University of Setif, Mohamed Abdenour Street, 19000 Setif, Algeria
| | - Chérifa Sedkaoui
- Department of Medical Oncology, Center University of Tizi Ouzou, Lamali Ahmed Street, 15000 Tizi Ouzou, Algeria
| | - Hayet Ammour
- Department of Medical Oncology, Center University of Tizi Ouzou, Lamali Ahmed Street, 15000 Tizi Ouzou, Algeria
| | - Adlane Dib
- Department of Medical Oncology, CAC Setif, 19000 Setif, Algeria
| | - Syhem Braikia
- Department of Medical Oncology, CAC Setif, 19000 Setif, Algeria
| | - Rime Reggad
- Department of Medical Oncology, CAC Setif, 19000 Setif, Algeria
| | - Habib Zidane
- Department of Medical Oncology, CAC Setif, 19000 Setif, Algeria
| | - Lamia Taieb
- Department of Medical Oncology, CAC Setif, 19000 Setif, Algeria
| | - Hassen Mahfouf
- Department of Medical Oncology, Public Hospital Rouiba Larbi Abdelsalem Street, 16000 Algiers, Algeria
| | - Amel Belacel
- Department of Medical Oncology, Public Hospital Rouiba Larbi Abdelsalem Street, 16000 Algiers, Algeria
| | - Zohra Mechiat
- Department of Medical Oncology, Public Hospital Rouiba Larbi Abdelsalem Street, 16000 Algiers, Algeria
| | - Yamina Maachou
- Department of Medical Oncology, Public Hospital Rouiba Larbi Abdelsalem Street, 16000 Algiers, Algeria
| | - Souad Souilah
- Department of Pneumology, Center University of Bab el Oued, Said Taouti Boulevard, 16000 Algiers, Algeria
| | - Malika Gamaz
- Department of Medical Oncology, Center Pierre Marie Curie, 1stMay place 1945, 16000 Algiers, Algeria
| | - Faiza Reguig
- Department of Medical Oncology, Cancer Center of Sidi Bel Abbas, Boulevard de Hospital, 22000 Sidi Bel Abbas, Algeria
| | - Sarah Tabouri
- Department of Medical Oncology, Cancer Center of Sidi Bel Abbas, Boulevard de Hospital, 22000 Sidi Bel Abbas, Algeria
| | - Meriem Bouannika
- Department of Medical Oncology, Cancer Center of Sidi Bel Abbas, Boulevard de Hospital, 22000 Sidi Bel Abbas, Algeria
| | - Soumeya Ghomari
- Department of Medical Oncology, Center University of Tlemcen, 05 Bd Mohammed V, 13000 Tlemcen, Algeria
| | - Amina Rostane
- Department of Medical Oncology, Center University of Tlemcen, 05 Bd Mohammed V, 13000 Tlemcen, Algeria
| | - Wassila Ougdi
- Department of Medical Oncology, Center University of Tlemcen, 05 Bd Mohammed V, 13000 Tlemcen, Algeria
| | - Lamia Belbachir
- Department of Medical Oncology, Center University of Tlemcen, 05 Bd Mohammed V, 13000 Tlemcen, Algeria
| | - Abdelkader Bousahba
- Department of Medical Oncology, Center University of Oran, Boulevard Docteur Benzerdjeb, Plateau, 31000 Oran, Algeria
| | - Fatima Seghier
- Department of Medical Oncology, Center University of Oran, Boulevard Docteur Benzerdjeb, Plateau, 31000 Oran, Algeria
| | - Ahlam Megaiz
- Department of Medical Oncology, Center University of Oran, Boulevard Docteur Benzerdjeb, Plateau, 31000 Oran, Algeria
| | - Amine Mesli Mohamed
- Department of Medical Oncology, Center University of Oran, Boulevard Docteur Benzerdjeb, Plateau, 31000 Oran, Algeria
| | - Merzak Gharnaout
- Department of Pneumology, Public Hospital Rouiba Larbi Abdelsalem Street, 16000 Algiers, Algeria
| | - Djidjelia Ihadadenne
- Department of Pneumology, Public Hospital Rouiba Larbi Abdelsalem Street, 16000 Algiers, Algeria
| | - Assia Bensalem
- Department of Medical Oncology, Public Hospital Didouche Mourad, Ain El Bir Didouche Mourad, 25000 Constantine, Algeria
| | - Samah Namous Anissa
- Department of Medical Oncology, Public Hospital Didouche Mourad, Ain El Bir Didouche Mourad, 25000 Constantine, Algeria
| | - Sabrina Djeghim
- Department of Medical Oncology, Public Hospital Didouche Mourad, Ain El Bir Didouche Mourad, 25000 Constantine, Algeria
| | - Sofiane Khelifi Touhami
- Department of Medical Oncology, Public Hospital Didouche Mourad, Ain El Bir Didouche Mourad, 25000 Constantine, Algeria
| | - Kamel Bouzid
- Department of Medical Oncology, Center Pierre Marie Curie, 1stMay place 1945, 16000 Algiers, Algeria
| | - Esma Kerboua
- Department of Medical Oncology, Center Pierre Marie Curie, 1stMay place 1945, 16000 Algiers, Algeria
| | - Mohammed Oukkal
- Department of Medical Oncology, Center University Beni Messous, Ibrahim Hadjeras Street, 16206 Beni Messous, Algeria
| | - Farida Hadjam
- Department of Medical Oncology, Center University Beni Messous, Ibrahim Hadjeras Street, 16206 Beni Messous, Algeria
| | - Farida Smaili
- University of Blida 1, Faculty of Medicine, BP 270, Route de soumaa, Blida, Algeria
| | - Sana Bekkouche
- University of Blida 1, Faculty of Medicine, BP 270, Route de soumaa, Blida, Algeria
| | - Noureddine Zidouni
- Department of Pneumo-physiology, Center University of Beni Messous, Ibrahim Hadjeras Street, 16206 Beni Messous, Algeria
| | - Dalila Mekideche
- Department of Pneumo-physiology, Center University of Beni Messous, Ibrahim Hadjeras Street, 16206 Beni Messous, Algeria
| | - Amina Mebrek
- Department of Pneumo-physiology, Center University of Beni Messous, Ibrahim Hadjeras Street, 16206 Beni Messous, Algeria
| | - Habib Douagui
- Department of Pneumo-allergology, Center University of Beni Messous, 16206 Beni Messous, Algeria
| | - Rachid Abdelaziz
- Department of Pneumo-allergology, Center University of Beni Messous, 16206 Beni Messous, Algeria
| | - Mohamed Lemdani
- Department of Pneumo-allergology, Center University of Beni Messous, 16206 Beni Messous, Algeria
| | - Ghania Malki
- Department of Pneumo-allergology, Center University of Beni Messous, 16206 Beni Messous, Algeria
| | - Aziza Fissah
- Department of Pneumology, Center University of Bab el Oued, Said Taouti Boulevard, 16000 Algiers, Algeria
| | - Blaha Larbaoui
- Department of Medical Oncology, Cancer Center of Oran Messerghine, 31031 Oran, Algeria
| | - Nawel Sadji
- Department of Medical Oncology, Cancer Center of Oran Messerghine, 31031 Oran, Algeria
| | - Sarra Zeroual
- Department of Medical Oncology, Cancer Center of Oran Messerghine, 31031 Oran, Algeria
| | - Taha Filali
- Department of Medical Oncology, Center University of Constantine, Cheikh Benbadis Street, 25000 Constantine, Algeria
| | - Lamia Ayadi
- Department of Medical Oncology, Center University of Constantine, Cheikh Benbadis Street, 25000 Constantine, Algeria
| | - Lilia Youcef Ali
- Department of Medical Oncology, Center University of Constantine, Cheikh Benbadis Street, 25000 Constantine, Algeria
| | - Abdelmadjid Djebbar
- Department of Pneumology, Public Hospital of Batna, Tazoult Street, 05000 Batna, Algeria
| | - Radia Heddane
- Department of Pneumology, Public Hospital of Batna, Tazoult Street, 05000 Batna, Algeria
| | - Bahrsia Haddad
- Department of Pneumology, Public Hospital of Batna, Tazoult Street, 05000 Batna, Algeria
| | - Hanene Djedi
- Department of Medical Oncology, Cancer Center of Annaba, Hospital Street, 23000 Annaba, Algeria
| | - Asma Yousfi
- Department of Medical Oncology, Cancer Center of Annaba, Hospital Street, 23000 Annaba, Algeria
| | - Lamia Debbah
- Department of Medical Oncology, Cancer Center of Annaba, Hospital Street, 23000 Annaba, Algeria
| | - Kada Boualga
- Department of Radiotherapy, Cancer Center of Blida, 02 Zabana Street, 09018 Blida, Algeria
| | - Ladj Ouali
- Department of Radiotherapy, Cancer Center of Blida, 02 Zabana Street, 09018 Blida, Algeria
| | - Zohra Guettaf Fatima
- Department of Radiotherapy, Cancer Center of Blida, 02 Zabana Street, 09018 Blida, Algeria
| | - Assia Moussei
- Department of Medical Oncology, Public Hospital of Sidi Ghiles Tipaza, 42000 Tipaza, Algeria
| | - Mourad Houri
- Department of Medical Oncology, Public Hospital of Sidi Ghiles Tipaza, 42000 Tipaza, Algeria
| | - Amal Haddouche
- AstraZeneca Algeria, Micro-business Park N°20-Bloc A, 6th Floor - Doudou Mokhtar Street, Hydra, 16035 Algiers, Algeria
| | - Meriem Kedar
- AstraZeneca Algeria, Micro-business Park N°20-Bloc A, 6th Floor - Doudou Mokhtar Street, Hydra, 16035 Algiers, Algeria
| |
Collapse
|